Santen Pharmaceutical Co., Ltd. (SNPHY)
Makes eye drops and medicines to treat glaucoma and allergies.
$12.43+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+12.7%
The outlook
SNPHY is trading near the middle of its 52-week range with a mixed trend against moving averages. Analyst coverage appears thin, and the stock carries a trailing P/E of 17.8. The overall sentiment leans slightly bullish, though price action remains flat today.
What’s behind the score
Price trendMixed vs its moving averages
52-week range68% of the way from its 52-week low to high
Market cap
$4.00B
52-wk high
$13.93
52-wk low
$9.22
50-day avg
$12.44
200-day avg
$11.10
Trailing P/E
17.8